NCT00866229|UnknownPhase 4DMC
Loading search results
Sponsor study identifier
interventional
140
1 country
1
Study Start
April 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2010
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 2010
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Early statin therapy in SLE patients that have high cholesterol level and other atherosclerosis risk should reduce atherosclerosis and coronary artery events in later course of disease. By the way, statin is used in restricted groups of rheumatologists due to awareness of side effects; myositis and hepatitis, that are frequently found in SLE patients more so than other groups of atherosclerosis patients and reporting data of autoimmune diseases that occur after statin use.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2010
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 2008
Date type not reportedThis date has not been verified as actual or estimated.
March 19, 2009
Actual (reported)March 20, 2009
Actual (reported)March 2010
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
June 2010
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Percentage reduction of LDL Cholesterol level
6 and 12 weeks
Proportion of patients that have transminitis, myositis or active SLE
6,12, 18 and 24 weeks
10 mg per day for 12 weeks
20 mg per day
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Bangkok, 10240, Thailand
Parawee Suwannalai, M.D.
Ramathibodi Hospital
First Submitted
March 19, 2009
First Posted
March 20, 2009
Study Start
April 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2010
Estimated (date passed)Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 2010
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
March 20, 2009
Record last verified: 2009-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: